Notice is hereby given that the U.S. Arctic Research Commission will hold its 99th meeting in Vancouver, British Columbia, Canada, on December 10-11, 2012. The business sessions, open to the public, will convene at 9 a.m. on December 10 and December 11. An afternoon meeting on December 10 from 2:15-5:30 p.m. will be closed to the public.
The Agenda items include:
The focus of the meeting will be reports and updates on programs and research projects affecting the Arctic.
If you plan to attend this meeting, please notify us via the contact information below. Any person planning to attend who requires special accessibility features and/or auxiliary aids, such as sign language interpreters, must inform the Commission of those needs in advance of the meeting.
Contact Person For Further Information: John Farrell, Executive Director, U.S. Arctic Research Commission, 703-525-0111 or TDD 703-306- 0090.
AGENCY: National Ocean Service, National Oceanic and Atmospheric Administration (NOAA), Department of Commerce.
ACTION: Notice of open meeting.
SUMMARY: The Hydrographic Services Review Panel (HSRP) is a Federal Advisory Committee established to advise the Under Secretary of Commerce for Oceans and Atmosphere on matters related to the responsibilities and authorities set forth in section 303 of the Hydrographic Services Improvement Act of 1998, its amendments, and such other appropriate matters that the Under Secretary refers to the Panel for review and advice.
Date and Time: The public meeting will be held on November 27-29, 2012. November 27th from 8:30 a.m. to 5:30 p.m.; November 28th from 8:30 a.m. to 5:30 p.m.; and November 29th from 8:30 a.m. to 5:30 p.m.
Location: Astor Crowne Plaza, 739 Canal Street, New Orleans, Louisiana, 70130, tel: (504) 962-0500. Refer to the HSRP Web site listed below for the most current meeting agenda. Times and agenda topics are subject to change.
FOR FURTHER INFORMATION CONTACT: Kathy Watson, HSRP Program Coordinator, National Ocean Service (NOS), Office of Coast Survey, NOAA (N/CS), 1315 East West Highway, Silver Spring, Maryland 20910; Telephone: 301-713-2770ext. 158; Fax: 301-713-4019; Email: Hydroservices.firstname.lastname@example.org or visit the NOAA HSRP Web site at http://nauticalcharts.noaa.gov/ocs/hsrp/hsrp.htm.
AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce.
ACTION: Notice of public meetings of the South Atlantic Fishery Management Council.
SUMMARY: In addition to a Council Member Visioning Workshop, the South Atlantic Fishery Management Council (Council) will hold a joint meeting of its Habitat and Environmental Protection Committee and Ecosystem- Based Management Committee; meetings of its Dolphin Wahoo Committee; Southeast Data, Assessment and Review (SEDAR) Committee; Snapper Grouper Committee; Ad Hoc Data Collection Committee; Personnel Committee (CLOSED SESSION); Executive Finance Committee; and a meeting of the Full Council. The Council will take action as necessary. The Council will also hold an informal public question and answer session regarding agenda items, and a formal public comment session. See SUPPLEMENTARY INFORMATION for additional details.
DATES: The Council meeting will be held December 3-7, 2012. See SUPPLEMENTARY INFORMATION for specific dates and times.
ADDRESSES: The meeting will be held at the Hilton Wilmington Riverside Hotel, 301 North Water Street, Wilmington, NC 28401; telephone: (1-888) 324-8170 or (910) 763-5900; fax: (910) 763-0038.
Council address: South Atlantic Fishery Management Council, 4055 Faber Place Drive, Suite 201, North Charleston, SC 29405.
FOR FURTHER INFORMATION CONTACT: Kim Iverson, Public Information Officer; telephone: (843) 571-4366 or toll free at (866) SAFMC-10; fax: (843) 769-4520; email: email@example.com.
AGENCY: Office of Science, Department of Energy.
ACTION: Notice of partially-closed meeting.
SUMMARY: This notice sets forth the schedule and summary agenda for a partially-closed meeting of the President's Council of Advisors on Science and Technology (PCAST), and describes the functions of the Council. Notice of this meeting is required under the Federal Advisory Committee Act (FACA), 5 U.S.C., App. 2.
DATES: November 30, 2012, 9:00 a.m. to 12:30 p.m.
ADDRESSES: National Academy of Sciences, 2101 Constitution Avenue NW., Washington, DC (in the Lecture Room).
FOR FURTHER INFORMATION CONTACT: Information regarding the meeting agenda, time, location, and how to register for the meeting is available on the PCAST Web site at: http://whitehouse.gov/ostp/pcast. A live video webcast and an archive of the webcast after the event are expected to be available at http://whitehouse.gov/ostp/pcast. The archived video will be available within one week of the meeting. Questions about the meeting should be directed to Dr. Amber Hartman Scholz, PCAST Acting Executive Director, at firstname.lastname@example.org, (202) 456-4444. Please note that public seating for this meeting is limited and is available on a first-come, first-served basis.
AGENCY: Environmental Protection Agency (EPA).
SUMMARY: Pursuant to the Federal Advisory Committee Act, the Environmental Protection Agency's (EPA's) Office of Pesticide Programs is giving notice that a public meeting of the Pesticide Program Dialogue Committee (PPDC) is scheduled for November 29-30, 2012. A draft agenda is under development and will be posted by November 16, 2012. Three PPDC workgroup meetings are scheduled to meet on November 28, 2012, as follows: PPDC Work Group on Integrated Pest Management; PPDC Work Group on Comparative Safety Statements; and PPDC Work Group on Pollinator Protection. The PPDC Work Group on 21st Century Toxicology/Integrated Testing Strategies will meet on November 29, 2012. All meetings are free, open to the public, and no advance registration is required.
DATES: The PPDC meeting will be held on Thursday, November 29, 2012, from 9 a.m. to 5 p.m., and Friday, November 30, 2012, from 9 a.m. to noon. On Wednesday, November 28, 2012, PPDC work group meetings are scheduled as follows: Integrated Pest Management from 1 p.m. to 4 p.m.; Comparative Safety Statements from 1 p.m. to 4 p.m.; and Pollinator Protection from 1 p.m. to 4 p.m.; and on Thursday, November 29, 2012, the PPDC Work Group on 21st Century Toxicology/Integrated Testing Strategies will meet from noon to 1:15 p.m. in N-4850-70 Potomac Yards North. Information regarding PPDC Work Groups is available on EPA's Web site at http://www.epa.gov/pesticides/ppdc/.
To request accommodation of a disability, please contact the person listed under FOR FURTHER INFORMATON CONTACT, preferably at least 10 days prior to the meeting, to give EPA as much time as possible to process your request.
ADDRESSES: The PPDC and Work Group meetings will be held at EPA's location at 1 Potomac Yard South, 2777 S. Crystal Drive, Arlington, VA. The PPDC meeting will be held in the lobby-level Conference Center. The PPDC Work Group on Pollinator Protection will meet on November 28, 2012, in the lobby-level Conference Center. The PPDC Work Group on Integrated Pest Management will meet on November 28, 2012, in room S- 4850-70 Potomac Yards South. The PPDC Work Group on Comparative Safety Statements will meet on November 28, 2012, in S-4370-80 Potomac Yards South. On November 29, 2012, the PPDC Work Group on 21st Century Toxicology/Integrated Testing Strategies will meet in N-4850-70 Potomac Yards North. EPA's Potomac Yard South building is approximately one mile from the Crystal City Metro Station.
FOR FURTHER INFORMATION CONTACT: Margie Fehrenbach, Office of Pesticide Programs (7501P), Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001; telephone number: (703) 308-4775; fax number: (703) 308-4776; email address: email@example.com.
Notice is hereby given of a change in the meeting of the Center for Scientific Review Advisory Council, October 31, 2012, 8:00 a.m. to October 31, 2012, 4:00 p.m., Health and Human Services Building, 5635 Fishers Lane, Rockville, MD 20852 which was published in the Federal Register on September 26, 2012, 77 FR 59202.
The meeting will be held on December 3, 2012, from 8:00 a.m. to 4:00 p.m. The meeting location remains the same. The meeting is open to the public.
Dated: November 6, 2012.
Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy.
GENCY: Food and Drug Administration, HHS.
ACTION: Notice of public hearing; request for comments.
SUMMARY: The Food and Drug Administration (FDA) is announcing a public hearing to obtain input on establishing a list of qualifying pathogens (i.e., those that have the potential to pose a serious threat to public health), as required under the Food and Drug Administration Safety and Innovation Act (FDASIA). This public hearing is being held to obtain comments from the public to determine the methodology that should be used in developing the list of qualifying pathogens, and to elicit suggestions for adding specific pathogens to the list.
DATES: Date and Time: The public hearing will be held on December 18, 2012, from 9 a.m. to 5 p.m. However, depending on the level of public participation, the hearing may be extended or may end early.
Location: The public hearing will be held at FDA's White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, the Great Room (rm. 1503), Silver Spring, MD 20993. Entrance for the public meeting participants (non-FDA employees) is through Building 1 where routine security check procedures will be performed. For parking and security information, please refer to http://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
Contact Person: Lee Lemley, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-7563, FAX: 301-847-8753, email: CDER-GAINPublicMtg@fda.hhs.gov.
Registration: The public hearing is free and seating will be on a first-come, first-served basis. Attendees who do not wish to make an oral presentation do not need to register.
If you need special accommodations due to a disability, please contact Lee Lemley (see Contact Person) at least 7 days in advance.
Requests for Oral Presentations: If you wish to make an oral presentation during the public hearing, you must register by submitting either an electronic or written request by close of business on December 3, 2012. You must provide your name, title, business affiliation (if applicable), address, email address, and phone and type of organization you represent (e.g., industry, consumer organization), and a brief summary of the presentation (including the discussion topic(s) that will be addressed) to Lee Lemley (see Contact Person). You should identify which question(s) set forth in section II of this document you wish to address so that FDA can consider that in organizing the presentations.
FDA will notify registered presenters of their scheduled times, and will make available an agenda at http://www.fda.gov/Drugs/NewsEvents/ucm319619.htm. Once FDA notifies registered presenters of their scheduled times, presenters should submit an electronic copy of their presentation to Lee Lemley (see Contact Person) no later than December 12, 2012. Persons registered to make an oral presentation should check in before the hearing, and are encouraged to arrive early to ensure the designated order of presentation.
A live Webcast of this public hearing will be viewable at the following Web site: https://collaboration.fda.gov/gain121812/. A video record of the public hearing will be available at the same Web site for 1 year.
Comments: Regardless of attendance at the public hearing, interested persons may submit either written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852 or electronic comments to http://www.regulations.gov. Submit electronic or written comments by December 3, 2012. You should annotate and organize your comments so that they identify the specific questions to which they refer. It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov.
To permit time for all interested persons to submit data, information, or views on this subject, the administrative record of the hearing will remain open until January 25, 2013.
Transcripts: Please be advised that as soon as a transcript is available, it will be accessible at http://www.regulations.gov. It may be viewed at the Division of Dockets Management (see Comments). A transcript will also be available in either hardcopy or on CD-ROM, after submission of a Freedom of Information request. Written requests are to be sent to the Division of Freedom of Information (ELEM-1029), Food and Drug Administration, 12420 Parklawn Dr., Element Bldg., Rockville, MD 20857.
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Advisory Committee to the Director, National Institutes of Health.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: Advisory Committee to the Director, National Institutes of Health.
Date: December 6-7, 2012.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: NIH Director's Report, ACD Working Group Implementation Team reports, NIH.
Place: Updates and other business of the Committee, National Institutes of Health, Building 31, C-Wing 6th Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20852.
Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 103, Bethesda, MD 20892, 301-496-4272, firstname.lastname@example.org.
Information is also available on the Institute's/Center's home page: http://acd.od.nih.gov, where an agenda and any additional information for the meeting will be posted when available.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government issued photo ID, driver's license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)
AGENCY: National Aeronautics and Space Administration.
ACTION: Notice of meeting.
SUMMARY: In accordance with the Federal Advisory committee Act, Public Law 92-462, as amended, the National Aeronautics and Space Administration (NASA) announces a meeting of the Science Committee of the NASA Advisory Council (NAC). This Committee reports to the NAC. The meeting will be held for the purpose of soliciting, from the scientific community and other persons, scientific and technical information relevant to program planning.
DATES: Wednesday, November 14, 2012, 8:30 a.m. to 4:30 p.m., and Thursday, November 15, 2012, 8:30 a.m. to 3:00 p.m., Local Time.
ADDRESSES: NASA Headquarters, 300 E Street SW., Rooms 3H46 and 9H40, respectively, Washington, DC 20546.
FOR FURTHER INFORMATION CONTACT: Ms. Marian Norris, Science Mission Directorate, NASA Headquarters, Washington, DC 20546, (202) 358-4452, fax (202) 358-4118, or email@example.com.